Datacentrex, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Datacentrex, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $2.4K | Mar 17, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.96M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $741 | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $2.0K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $2.4K | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.4K | Aug 17, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.40M | Apr 13, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.50M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | ($4.00M) | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | ($3.32M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($1.50M) | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | ($857.3K) | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | ($5.7K) | Mar 17, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.92M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | ($3.95M) | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | ($2.52M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($1.21M) | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | ($839.8K) | Aug 17, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $244.9K | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $513.1K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $567.4K | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $716.5K | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.7K | Mar 17, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.8K | Apr 13, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.45M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | ($3.49M) | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | ($2.33M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($1.08M) | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | ($813.2K) | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | ($13.7K) | Mar 17, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.94M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $11.1K | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $8.0K | Mar 11, 2025 |
| FY2022 | Dec 31, 2021 | $6.4K | Aug 17, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.84M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $5.10M | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $415.2K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $1.16M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $429.2K | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | $211.3K | Mar 17, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $335.2K | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $65.9K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $374.3K | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $249.3K | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | $217.0K | Mar 17, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.25M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $4.77M | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $349.3K | Mar 11, 2025 |
| FY2024 | Dec 31, 2022 | $786.5K | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $179.8K | Mar 20, 2024 |
| FY2022 | Dec 31, 2020 | ($5.7K) | Aug 17, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.50M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | ($9.69M) | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | ($5.69M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($2.37M) | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | ($862.9K) | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | ($5.7K) | Mar 17, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.92M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | $4.68M | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | $259.2K | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $1.16M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $424.4K | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | $101.3K | Mar 17, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Aug 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | 0 | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Aug 17, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.38M | Apr 13, 2026 |
| FY2024 | Dec 31, 2024 | 9.40M | Mar 11, 2025 |
| FY2024 | Dec 31, 2023 | 7.66M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 7.11M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 6.04M | Aug 17, 2023 |
| FY2021 | Dec 31, 2020 | 5.00M | Mar 17, 2022 |